Abstract
Atrial fibrillation (AF) continues to offer a management challenge to physicians. The incidence of this arrhythmia is rising and the cost to the healthcare system is vast. Much of this health burden relates to the high risk of stroke and thromboembolism associated with AF. This review covers common treatment strategies employed in AF management, discusses relevant drug therapy and the role of electrophysiology or surgery.
MeSH terms
-
Anti-Arrhythmia Agents / therapeutic use*
-
Atrial Fibrillation* / complications
-
Atrial Fibrillation* / epidemiology
-
Atrial Fibrillation* / therapy
-
Cardiac Surgical Procedures / methods*
-
Electric Countershock / methods*
-
Fibrinolytic Agents / therapeutic use
-
Global Health
-
Humans
-
Incidence
-
Outcome Assessment, Health Care / trends*
-
Practice Guidelines as Topic*
-
Prevalence
-
Stroke / epidemiology
-
Stroke / etiology
-
Stroke / prevention & control
-
Thromboembolism / epidemiology
-
Thromboembolism / etiology
-
Thromboembolism / prevention & control
Substances
-
Anti-Arrhythmia Agents
-
Fibrinolytic Agents